Home / Cancer and immune system / Idarubicin
ATC L01DB06 · Antineoplastic Agents
Idarubicin shortage
As of 31 Oct 2026, Idarubicin has a reported shortage in 3 of the 5 countries we track (Germany, Italy, Spain), covering 5 products.
Countries3/5
Products5packs or presentations
Short since13 Jan 202522 months ago
Earliest return30 Nov 2026company estimate
No return date3products
Main reasonOther
Timeline
GermanyItalySpain
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | Idarubicin HEXAL 1 mg/ml Konzentrat zur Herstellung einer Infusionslösung | H e x a l Aktiengesellschaft | 19 May 2026 | 19 Feb 2027 | Other Sonstige |
| DE | Idarubicin Hikma 1 mg/ml Injektionslösung | Hikma Pharma GmbH | 13 Jul 2026 | 30 Nov 2026 | Other Sonstige |
| IT | ZAVEDOS | PFIZER ITALIA S.R.L. | 20 Oct 2026 | not given | Manufacturing problem Problemi produttivi |
| ES | ZAVEDOS 1MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 5 ml | Pfizer S.L. | 13 Jan 2025 | not given | Not stated |
| ES | ZAVEDOS 1MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | Pfizer S.L. | 28 Oct 2026 | not given | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.